GROWTH
Top line decelerating.
+5.0% YoY versus +8.4% prior. 3y CAGR +7.3%.
+5.0%
The Cooper Companies, Inc. COO
Healthcare · Market Cap: $13.2B
Live price unavailable
Fundamentals as of 2026-04-30
We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $13.2B
Live price unavailable
Fundamentals as of 2026-04-30
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
+5.0% YoY versus +8.4% prior. 3y CAGR +7.3%.
+5.0%Net margin 9.2% versus 10.1% prior (−0.9pp). Operating 16.7%.
9.2%P/E 57.1x — 52% above the 5y median of 37.5x. Forward 14.6x hints at EPS expansion next year.
57.1xConcerns — The Cooper Companies, Inc.'s 2.9% ROE is below sector median.
Financial story
Concerns — The Cooper Companies, Inc.'s 2.9% ROE and 0.52 debt-to-equity warrant a closer look at the underlying business.
Bottom line: COO currently has no legendary investor models qualifying — see /stock/COO/valuation for the per-model breakdown, but earns a C sector grade (45/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
0 of 6 legendary investor models rate COO a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
The Cooper Companies, Inc.'s fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
COO trades at 57.1x earnings. Sector context and per-investor signals are in the valuation tab.
COO and NBIX differ on P/E, ROE, and revenue growth. See the full COO vs NBIX compare matrix.
Investor verdicts for COO are listed in the valuation tab. Per-model fair value and reasoning are in the valuation tab.
COO's P/E ratio is 57.1x. 5-year P/E history is in the
How does COO compare?
See exactly where COO ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingCOO sits at #74 in Healthcare with a C grade (45/100).
